InvestorsHub Logo
icon url

Volcano

03/15/16 8:33 PM

#29992 RE: Learjetter #29989

Maybe a few mil value
Nothing was proven yet and nobody
Wants to give the fund as of now
They should have done financing for
This long period.
The mgmt is incompetent
These shares are not even restricted
and can be dilluted any day now
icon url

Diamondhands45

03/15/16 8:41 PM

#29996 RE: Learjetter #29989

Re: Volcano Post# 29988
The 321 million shares was for the patents to discharge the debt. So how does discharging all debt with shares valued 5 times where we are now do as you say. Phase 1 costs
Very little. They would only need 5-10 million. They could almost partner up for this drug. Not sure if you understand this drug but it is almost identical to etoposide with only one small side chain variation that allows for its effectiveness against multi drug resistant cancers with no current treatments. This thing is about as slam dunk as you can get in bio this early in the process. The preclinical safety and pharmacokinetics was identical to etoposide and it will
Get bought out in phase 1 IMO.


Report TOS